Rat Study Shows Gut Dysbiosis Impacts Systolic Blood Pressure

This article originally appeared here.
Share this content:
Rat Study Shows Gut Dysbiosis Impacts Systolic Blood Pressure
Rat Study Shows Gut Dysbiosis Impacts Systolic Blood Pressure

THURSDAY, Feb. 9, 2017 (HealthDay News) -- Gut dysbiosis seems to affect systolic blood pressure (SBP) in a rat model, according to an experimental study published recently in Physiological Genomics.

Sareema Adnan, from the University of Houston, and colleagues pooled cecal contents from spontaneously hypertensive stroke prone rats (SHRSP) and from normotensive WKY rats. The rats were treated with antibiotics to reduce the native microbiota and were then gavaged with either WKY or SHRSP microbiota, resulting in four groups: WKY with WKY microbiota (WKY g-WKY), WKY with SHRSP microbiota (WKY g-SHRSP), SHR with SHRSP microbiota (SHR g-SHRSP), and SHR with WKY microbiota (SHR g-WKY).

The researchers found that systolic blood pressure (SBP) increased 26 mm Hg at 11.5 weeks of age in WKY g-SHRSP versus WKY g-WKY (P = 0.02). Compared with SHR g-SHRSP, SBP tended to decrease in SHR-g WKY, although the differences were not statistically significant. On collection of fecal pellets at 11.5 weeks of age there was a significant increase in the Firmicutes:Bacteroidetes ratio in hypertensive WKY g-SHRSP, compared with the normotensive WKY g-WKY (P = 0.042). There was a correlation between relative abundance of multiple taxa and SBP.

"The present study is the first demonstrating a causal role of the gut microbiota in the development of hypertension in the SHR model," the authors write. "We demonstrate that the SHRSP microbiota is capable of increasing blood pressure in the normotensive WKY parent strain."

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves New Parkinson's Add-On Drug Xadago

FDA Approves New Parkinson's Add-On Drug Xadago

To help prevent 'off' episodes among users of levodopa/carbidopa

Infant Mortality Down in United States From 2005 to 2014

Infant Mortality Down in United States From 2005 ...

Largest decreases seen for infants of Asian or Pacific Islander and non-Hispanic black women

Intensive Strategy Addresses Hypoxemia After Cardiac Surgery

Intensive Strategy Addresses Hypoxemia After Cardiac Surgery

Intensive alveolar recruitment strategy linked to less severe pulmonary complications after cardiac sx

is free, fast, and customized just for you!

Already a member?

Sign In Now »